The Dehydroepiandrosterone And WellNess (DAWN) study: Research design and methods

Contemporary Clinical Trials

Volumn 28, Issue 2, 2007, Pages 153-168

  von Mühlen, Denise ^a   Laughlin, Gail A ^a   Kritz Silverstein, Donna ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Clinical trial; Dehydroepiandrosterone

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; PLACEBO; PRASTERONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BODY COMPOSITION; BONE DENSITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG METABOLISM; DRUG MONITORING; DRUG TRANSFORMATION; EXERCISE; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL RESEARCH; MOOD CHANGE; MUSCLE STRENGTH; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SEXUALITY; SMOKING; STEROID BLOOD LEVEL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WELLBEING;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; AGING; BODY COMPOSITION; BONE DENSITY; CALIFORNIA; COGNITION; CYTOKINES; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PLACEBOS; QUALITY OF LIFE;

EID: 33845594342     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2006.04.009     Document Type: Article

References (92)

1. Labrie F. Intracrinology. Mol Cell Endocrinol 78 3 (1991) C113-C118
2. Labrie F., Belanger A., Cusan L., Gomez J.L., and Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82 8 (1997) 2396-2402
3. Bjornerem A., Straume B., Midtby M., et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: The Tromso Study. J Clin Endocrinol Metab 89 12 (2004) 6039-6047
4. Belanger B., Belanger A., Labrie F., Dupont A., Cusan L., and Monfette G. Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men. J Steroid Biochem 32 5 (1989) 695-698
5. Arlt W., Haas J., Callies F., et al. Biotransformation of oral dehydroepiandrosterone in elderly men: Significant increase in circulating estrogens. J Clin Endocrinol Metab 84 6 (1999) 2170-2176
6. Wolf O.T., Kudielka B.M., Hellhammer D.H., Hellhammer J., and Kirschbaum C. Opposing effects of DHEA replacement in elderly subjects on declarative memory and attention after exposure to a laboratory stressor. Psychoneuroendocrinology 23 6 (1998) 617-629
7. Wolf O.T., Neumann O., Hellhammer D.H., et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 82 7 (1997) 2363-2367
8. Khorram O., Vu L., and Yen S.S. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci 52 1 (1997) M1-M7
9. Morales A.J., Nolan J.J., Nelson J.C., and Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78 6 (1994) 1360-1367
10. Arlt W., Justl H.G., Callies F., et al. Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83 6 (1998) 1928-1934
11. Villareal D.T. Effects of dehydroepiandrosterone on bone mineral density: What implications for therapy?. Treat Endocrinol 1 6 (2002) 349-357
12. Labrie F. Adrenal androgens and intracrinology. Semin Reprod Med 22 4 (2004) 299-309
13. Leng S.X., Cappola A.R., Andersen R.E., et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16 2 (2004) 153-157
14. Kahn A.J., Halloran B., Wolkowitz O., and Brizendine L. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. J Clin Endocrinol Metab 87 4 (2002) 1544-1549
15. Evans J.W. What is sarcopenia. J Gerontol 50A (1995) 5-8
16. Tenover J.S. Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men. Baillieres Clin Endocrinol Metab 12 3 (1998) 419-425
17. Proctor D.N., Balagopal P., and Nair K.S. Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. J Nutr 128 2 Suppl (1998) 351S-355S
18. Yen S.S., Morales A.J., and Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann N Y Acad Sci 774 (1995) 128-142
19. Straub R.H., Konecna L., Hrach S., et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83 6 (1998) 2012-2017
20. James K., Premchand N., Skibinska A., Skibinski G., Nicol M., and Mason J.I. IL-6, DHEA and the ageing process. Mech Ageing Dev 93 1-3 (1997) 15-24
21. Josipovic B. Levels of dehydroepiandrosterone sulfate in female patients with early stage of rheumatoid arthritis. Ann N Y Acad Sci 876 (1999) 145-147
22. Giltay E.J., van Schaardenburg D., Gooren L.J., and Dijkmans B.A. Dehydroepiandrosterone sulfate in patients with rheumatoid arthritis. Ann N Y Acad Sci 876 (1999) 152-154
23. Cutolo M., Foppiani L., Prete C., et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 26 2 (1999) 282-288
24. Derksen R.H. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. Semin Arthritis Rheum 27 6 (1998) 335-347
25. de la Torre B., Fransson J., and Scheynius A. Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis. Clin Exp Rheumatol 13 3 (1995) 345-348
26. Jacobson M.A., Fusaro R.E., Galmarini M., and Lang W. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis 164 5 (1991) 864-868
27. Mulder J.W., Frissen P.H., Krijnen P., et al. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 165 3 (1992) 413-418
28. Marmorston J., Lewis J.J., Bernstein J.L., et al. Excretion of urinary steroids by men and women with myocardial infarction. Geriatrics 12 5 (1957) 297-300
29. Rao L.G. Urinary steroid-excretion patterns after acute myocardial infarction. Lancet 2 7669 (1970) 390-391
30. Phillips G.B., Pinkernell B.H., and Jing T.Y. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 17 4 (1997) 695-701
31. Herrington D.M., Nanjee N., Achuff S.C., Cameron D.E., Dobbs B., and Baughman K.L. Dehydroepiandrosterone and cardiac allograft vasculopathy. J Heart Lung Transplant 15 1 Pt 1 (1996) 88-93
32. Mitchell L.E., Sprecher D.L., Borecki I.B., Rice T., Laskarzewski P.M., and Rao D.C. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation 89 1 (1994) 89-93
33. Herrington D.M., Gordon G.B., Achuff S.C., et al. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 16 6 (1990) 862-870
34. Sherwin B.B. Sex hormones and psychological functioning in postmenopausal women. Exp Gerontol 29 3-4 (1994) 423-430
35. Ditkoff E.C., Crary W.G., Cristo M., and Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78 6 (1991) 991-995
36. Reiter T. Testosterone implantation: A clinical study of 240 implantations in ageing males. J Am Geriatr Soc 11 (1963) 540-550
37. Bahrke M.S., Yesalis III C.E., and Wright J.E. Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review. Sports Med 10 5 (1990) 303-337
38. Osran H., Reist C., Chen C.C., Lifrak E.T., Chicz-DeMet A., and Parker L.N. Adrenal androgens and cortisol in major depression. Am J Psychiatry 150 5 (1993) 806-809
39. Heuser I., Deuschle M., Luppa P., Schweiger U., Standhardt H., and Weber B. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83 9 (1998) 3130-3133
40. Barrett-Connor E., von Mühlen D., Laughlin G.A., and Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo Study. J Am Geriatr Soc 47 6 (1999) 685-691
41. Berr C., Lafont S., Debuire B., Dartigues J.F., and Baulieu E.E. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study. Proc Natl Acad Sci U S A 93 23 (1996) 13410-13415
42. Yaffe K., Ettinger B., Pressman A., et al. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study. Biol Psychiatry 43 9 (1998) 694-700
43. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
44. Cawood E.H., and Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 26 5 (1996) 925-936
45. Arlt W., Callies F., van Vlijmen J.C., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341 14 (1999) 1013-1020
46. Labrie F., Diamond P., Cusan L., Gomez J.L., Belanger A., and Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82 10 (1997) 3498-3505
47. Flynn M.A., Weaver-Osterholtz D., Sharpe-Timms K.L., Allen S., and Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 84 5 (1999) 1527-1533
48. Rosen R., Brown C., Heiman J., et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26 2 (2000) 191-208
49. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., and Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 49 6 (1997) 822-830
50. Legrain S., Berr C., Frenoy N., Gourlet V., Debuire B., and Baulieu E.E. Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology 41 6 (1995) 343-351
51. Schneider L.S., Hinsey M., and Lyness S. Plasma dehydroepiandrosterone sulfate in Alzheimer's disease. Biol Psychiatry 31 2 (1992) 205-208
52. Nasman B., Olsson T., Backstrom T., et al. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 30 7 (1991) 684-690
53. Kalmijn S., Launer L.J., Stolk R.P., et al. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J Clin Endocrinol Metab 83 10 (1998) 3487-3492
54. Barrett-Connor E., and Edelstein S.L. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study. J Am Geriatr Soc 42 4 (1994) 420-423
55. Berkman L.F., Seeman T.E., Albert M., et al. High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol 46 10 (1993) 1129-1140
56. Tilvis R.S., Kahonen M., and Harkonen M. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population. Aging (Milano) 11 1 (1999) 30-34
57. Teng E.L., and Chui H.C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 8 (1987) 314-318
58. Fromm-Auch D., and Yeudall L.T. Normative data for the Halstead-Reitan neuropsychological tests. J Clin Neuropsychol 5 3 (1983) 221-238
59. Borkowski J.G., Benton A.L., and Spreen O. Word fluency and brain damage. Neuropsychologia 5 (1967) 135-140
60. Kaplan E., Goodglass H., and Weintraub S. The Boston Naming Test (1982), Lea and Febiger, Philadelphia, Pa
61. Buschke H., and Fuld P.A. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24 11 (1974) 1019-1025
62. Tummala S., and Svec F. Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: Analysis of published data. Clin Biochem 32 5 (1999) 355-361
63. Mortola J.F., and Yen S.S. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71 3 (1990) 696-704
64. Casson P.R., Santoro N., Elkind-Hirsch K., et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six-month trial. Fertil Steril 70 1 (1998) 107-110
65. Legrain S., Massien C., Lahlou N., et al. Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 85 9 (2000) 3208-3217
66. Liu C.H., Laughlin G.A., Fischer U.G., and Yen S.S. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: Evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 71 4 (1990) 900-906
67. Toniolo P., Bleich A.R., Beinart C., and Koenig K.L. Reproducibility of Wolfe's classification of mammographic parenchymal patterns. Prev Med 21 1 (1992) 1-7
68. Greendale G.A., Reboussin B.A., Sie A., et al., Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med 130 4 Pt 1 (1999) 262-269
69. Schuit A.J., Schouten E.G., Westerterp K.R., and Saris W.H. Validity of the Physical Activity Scale for the Elderly (PASE): According to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol 50 5 (1997) 541-546
70. Washburn R.A., McAuley E., Katula J., Mihalko S.L., and Boileau R.A. The Physical Activity Scale for the Elderly (PASE): Evidence for validity. J Clin Epidemiol 52 7 (1999) 643-651
71. Pouliot M.C., Despres J.P., Lemieux S., et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73 7 (1994) 460-468
72. Bassey E.J., and Harries U.J. Normal values for handgrip strength in 920 men and women aged over 65 years, and longitudinal changes over 4 years in 620 survivors. Clin Sci (Lond) 84 3 (1993) 331-337
73. The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med 5 (2) (1976) 207-215.
74. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
75. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 6 (1972) 499-502
76. Clauss. Acta Haemat 17 (1957) 237
77. Wood V., Wylie M.L., and Sheafor B. An analysis of a short self-report measure of life satisfaction: Correlation with rater judgments. J Gerontol 24 4 (1969) 465-469
78. Stewart A.L., Hays R.D., and Ware Jr. J.E. The MOS Short-Form General Health Survey. Reliability and validity in a patient population. Med Care 26 7 (1988) 724-735
79. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30 6 (1992) 473-483
80. Morris J.C., Heyman A., Mohs R.C., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 9 (1989) 1159-1165
81. Welsh K.A., Butters N., Mohs R.C., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 44 4 (1994) 609-614
82. Anderson D.C., Hopper B.R., Lasley B.L., and Yen S.S. A simple method for the assay of eight steroids in small volumes of plasma. Steroids 28 2 (1976) 179-196
83. Sodergard R., Backstrom T., Shanbhag V., and Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 16 6 (1982) 801-810
84. Ferriman D., and Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21 (1961) 1440-1447
85. Barrett-Connor E., and Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Ann N Y Acad Sci 774 (1995) 259-270
86. Laird N.M., Donnelly C., and Ware J.H. Longitudinal studies with continuous responses. Stat Methods Med Res 1 3 (1992) 225-247
87. Freedman L.S., Spiegelhalter D.J., and Parmar M.K. The what, why and how of Bayesian clinical trials monitoring. Stat Med 13 13-14 (1994) 1371-1383 [discussion 1385-9]
88. Senn S. Testing for baseline balance in clinical trials. Stat Med 13 17 (1994) 1715-1726
89. Carr G.J., and Chi E.M. Analysis of variance for repeated measures. Data: A generalized estimating equations approach. Stat Med 11 8 (1992) 1033-1040
90. Lipsitz S.R., and Harrington D.P. Analyzing correlated binary data using SAS. Comput Biomed Res 23 3 (1990) 268-282
91. Norusis M.J. SPSS 12.0 statistical procedures companion (2003), Prentice Hall, New Jersey
92. Espeland M.A., Byington R.P., Hire D., Davis V.G., Hartwell T., and Probstfield J. Analysis strategies for serial multivariate ultrasonographic data that are incomplete. Stat Med 11 8 (1992) 1041-1056